Stock Movers

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Scarlet Fu, Tim Stenovec, Carol Massar

- Meta Platforms (META) released a new artificial intelligence model called Muse Wonder, which the company claims is a big leap over its predecessors with "frontier capabilities". The model is said to be competitive with OpenAI's ChatGPT and Anthropic PBC's Claude, particularly in coding, financial, or legal questions, and will soon power the subscription version of Meta's personal AI agent Muse. Meta AI Chief Alexandr Wang says the company has tried to differentiate itself from competitors by focusing on big models for broad, consumer uses, and is already working on larger and more scaled models, as well as specialized versions that are efficient enough to deploy at massive scale. Meta’s shares rose as high as 4.7% on the announcement.

- IonQ (IONQ) declined 9.2% after the company said it would acquire enterprise security start-up Elisity for as much as $1.3 billion in an all-stock transaction. The stock dropped Monday on potential investor concerns that the company has scaled too quickly.

- Chipotle (CMG) shares are trading lower after Starbucks denied that it is considering acquiring the fast-casual chain. The deal rumors had sent Chipotle shares higher and Starbucks shares lower, with Chipotle investors looking forward to a potential reunion with Brian Niccol, who previously led Chipotle and is now CEO of Starbucks.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market, a look at the notable movers:
On this episode of Stock Movers:

- Chipotle (CMG) shares are trading lower after Starbucks (SBUX) denied that it is considering acquiring the fast-casual chain. The deal rumors had sent Chipotle shares higher and Starbucks shares lower, with Chipotle investors looking forward to a potential reunion with Brian Niccol, who previously led Chipotle and is now CEO of Starbucks.

- Bristol Myers (BMY) shares erase earlier gains to fall as much as 3.9% after the drugmaker reported mixed results from a late-stage trial of its drug candidate for a lung disease, where a lower dose was more successful than a high-dose version of the therapy. Analysts tout concerns about the dose response, with RBC Capital Markets calling it “confounding” and requiring further explanation.

- Salesforce (CRM) shares jump after BofA Global Research raised the recommendation on the software company to buy from underperform, pointing to tailwinds from AI adoption. The firm said Salesforce's enterprise artificial-intelligence strategy has reduced risks of AI disruption and that large enterprises were unlikely to replace platforms like Salesforce that contain their business logic and data Salesforce has also signed a definitive agreement to acquire Loops, an AI-powered analytics platform that monitors business performance, explains metric changes and surfaces improvement opportunities using machine learning.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Salesforce (CRM) shares gain. BofA Global Research raised the recommendation on the software company to buy from underperform, pointing to tailwinds from AI adoption.
- Adobe (ADBE) shares are down. Wells Fargo Securities downgraded the maker of software for creative professionals by two notches, to underweight from overweight.
- Chipotle (CMG) shares fall. Starbucks Corp. said it’s not buying Chipotle Mexican Grill Inc, seeking to tamp down speculation about what could have been one of the restaurant sector’s largest-ever deals. The company issued a statement on Monday following a report last week that Starbucks, run by former Chipotle Chief Executive Officer Brian Niccol, had worked on a takeover proposal.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Bristol Myers (BMY) shares climb. Bristol Myers Squibb Co.’s experimental drugs for treating a rare endocrine cancer and a deadly form of lung disease showed promise in late-stage studies, a potential boon for the pharmaceutical company’s new product pipeline. Wall Street has been eagerly anticipating both results, as the drugs use novel approaches for hard-to-treat conditions that impair patients’ quality of life and are eventually fatal.
- Adobe (ADBE) shares drop. Wells Fargo Securities downgraded the maker of software for creative professionals by two notches, to underweight from overweight.
- Salesforce (CRM) shares gain. BofA Global Research raised the recommendation on the software company to buy from underperform, pointing to tailwinds from AI adoption.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Amazon (AMZN) shares are moving on news it's in negotiations to acquire Decart AI, an artificial intelligence startup, in a deal that could be valued at around $7 billion, the Wall Street Journal reported.
The purchase could be wrapped up soon if the negotiations don’t collapse, the Journal said, citing people familiar with the matter.
- IonQ (IONQ) shares are moving after it agreed to buy Elisity for as much as $1.3 billion in an all-stock transaction to expand its cybersecurity platform. IonQ Chief Executive Officer Niccolo de Masi said the company will be well positioned to help customers protect critical infrastructure and enterprise networks throughout the transition to the quantum era.
- T-Mobile (TMUS) shares are rising after Raymond James upgraded the stock to outperform from market perform, noting that the recent pullback in shares has created a buying opportunity. Analyst Frank Louthan says the “recent fears over SpaceX competition are overblown, as it is three-plus years from becoming a reality.”
See omnystudio.com/listener for privacy information.